| 4-HNE | 4-hydroxynonenal |
| AGE | advanced glycation end products |
| BBB | blood–brain barrier |
| BCA | bicinchoninic acid |
| BCAA | branched-chain amino acids |
| BHT | butylated hydroxytoluene |
| CAT | catalase |
| CNS | central nervous system |
| FRAP | ferric reducing ability of plasma |
| GAPDH | glyceraldehyde 3-phosphate dehydrogenase |
| GPx | glutathione peroxidase |
| GR | glutathione reductase |
| GSH | reduced glutathione |
| HOMA-IR | homeostatic model assessment of β-cell function and insulin resistance |
| HPD | high protein diet |
| MDA | malondialdehyde |
| NADPH | nicotinamide adenine dinucleotide phosphate |
| NFκB | nuclear factor-κB |
| OS | oxidative stress |
| OSI | oxidative stress index |
| PBS | phosphate buffered saline |
| PUFAs | polyunsaturated fatty acids |
| RAGE | receptor for advanced glycation end products |
| ROS | reactive oxygen species |
| SDS-PAGE | sodium dodecyl sulfate-polyacrylamide gel electrophoresis |
| SIRT-1 | sirtuin 1 |
| SOD-1 | superoxide dismutase-1 |
| TAC | total antioxidant capacity |
| TBARS | thiobarbituric acid reactive substances |
| TNF-alpha | tumor necrosis factor alpha |
| TOS | total oxidant status |
| UA | uric acid |
| WHO | World Health Organization |